Logo image of AVTR

AVANTOR INC (AVTR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AVTR - US05352A1007 - Common Stock

11.74 USD
-0.11 (-0.93%)
Last: 11/26/2025, 8:04:00 PM
11.74 USD
0 (0%)
After Hours: 11/26/2025, 8:04:00 PM
Fundamental Rating

4

AVTR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of AVTR while its profitability can be described as average. AVTR is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year AVTR was profitable.
AVTR had a positive operating cash flow in the past year.
In the past 5 years AVTR has always been profitable.
AVTR had a positive operating cash flow in each of the past 5 years.
AVTR Yearly Net Income VS EBIT VS OCF VS FCFAVTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of AVTR (-0.70%) is better than 62.07% of its industry peers.
AVTR's Return On Equity of -1.48% is fine compared to the rest of the industry. AVTR outperforms 62.07% of its industry peers.
AVTR's Return On Invested Capital of 4.80% is fine compared to the rest of the industry. AVTR outperforms 70.69% of its industry peers.
AVTR had an Average Return On Invested Capital over the past 3 years of 6.58%. This is significantly below the industry average of 13.53%.
Industry RankSector Rank
ROA -0.7%
ROE -1.48%
ROIC 4.8%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
AVTR Yearly ROA, ROE, ROICAVTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

AVTR's Profit Margin has improved in the last couple of years.
AVTR has a Operating Margin of 9.18%. This is in the better half of the industry: AVTR outperforms 67.24% of its industry peers.
AVTR's Operating Margin has improved in the last couple of years.
The Gross Margin of AVTR (33.13%) is worse than 65.52% of its industry peers.
AVTR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.18%
PM (TTM) N/A
GM 33.13%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
AVTR Yearly Profit, Operating, Gross MarginsAVTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVTR is destroying value.
AVTR has more shares outstanding than it did 1 year ago.
AVTR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AVTR has been reduced compared to a year ago.
AVTR Yearly Shares OutstandingAVTR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AVTR Yearly Total Debt VS Total AssetsAVTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that AVTR is in the distress zone and has some risk of bankruptcy.
AVTR has a Altman-Z score (1.79) which is in line with its industry peers.
AVTR has a debt to FCF ratio of 7.37. This is a slightly negative value and a sign of low solvency as AVTR would need 7.37 years to pay back of all of its debts.
AVTR's Debt to FCF ratio of 7.37 is fine compared to the rest of the industry. AVTR outperforms 60.34% of its industry peers.
AVTR has a Debt/Equity ratio of 0.65. This is a neutral value indicating AVTR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, AVTR is doing worse than 72.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 7.37
Altman-Z 1.79
ROIC/WACC0.51
WACC9.46%
AVTR Yearly LT Debt VS Equity VS FCFAVTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.49 indicates that AVTR should not have too much problems paying its short term obligations.
AVTR has a worse Current ratio (1.49) than 75.86% of its industry peers.
A Quick Ratio of 0.96 indicates that AVTR may have some problems paying its short term obligations.
The Quick ratio of AVTR (0.96) is worse than 82.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.96
AVTR Yearly Current Assets VS Current LiabilitesAVTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

AVTR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.04%.
The earnings per share for AVTR have been decreasing by -10.82% on average. This is quite bad
The Revenue has decreased by -3.59% in the past year.
Measured over the past years, AVTR shows a small growth in Revenue. The Revenue has been growing by 2.35% on average per year.
EPS 1Y (TTM)-2.04%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)-3.59%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-5.28%

3.2 Future

The Earnings Per Share is expected to grow by 5.40% on average over the next years.
AVTR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.67% yearly.
EPS Next Y-7.13%
EPS Next 2Y-2.78%
EPS Next 3Y2.39%
EPS Next 5Y5.4%
Revenue Next Year-3.96%
Revenue Next 2Y-1.79%
Revenue Next 3Y0.18%
Revenue Next 5Y1.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AVTR Yearly Revenue VS EstimatesAVTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
AVTR Yearly EPS VS EstimatesAVTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.23, the valuation of AVTR can be described as correct.
98.28% of the companies in the same industry are more expensive than AVTR, based on the Price/Earnings ratio.
AVTR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
AVTR is valuated correctly with a Price/Forward Earnings ratio of 12.42.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AVTR indicates a rather cheap valuation: AVTR is cheaper than 98.28% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AVTR to the average of the S&P500 Index (36.12), we can say AVTR is valued rather cheaply.
Industry RankSector Rank
PE 12.23
Fwd PE 12.42
AVTR Price Earnings VS Forward Price EarningsAVTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVTR is valued cheaply inside the industry as 98.28% of the companies are valued more expensively.
AVTR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AVTR is cheaper than 93.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.29
EV/EBITDA 11.48
AVTR Per share dataAVTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of AVTR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.78%
EPS Next 3Y2.39%

0

5. Dividend

5.1 Amount

No dividends for AVTR!.
Industry RankSector Rank
Dividend Yield N/A

AVANTOR INC

NYSE:AVTR (11/26/2025, 8:04:00 PM)

After market: 11.74 0 (0%)

11.74

-0.11 (-0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners103.37%
Inst Owner Change-5.17%
Ins Owners0.34%
Ins Owner Change6.07%
Market Cap8.00B
Revenue(TTM)6.58B
Net Income(TTM)-82.20M
Analysts71.11
Price Target14 (19.25%)
Short Float %3.34%
Short Ratio2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.53%
Min EPS beat(2)-5.09%
Max EPS beat(2)-3.97%
EPS beat(4)1
Avg EPS beat(4)-2.12%
Min EPS beat(4)-5.09%
Max EPS beat(4)2.94%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)6
Avg EPS beat(12)0.63%
EPS beat(16)9
Avg EPS beat(16)1.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.91%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)-1.44%
Revenue beat(8)0
Avg Revenue beat(8)-2.36%
Revenue beat(12)0
Avg Revenue beat(12)-2.35%
Revenue beat(16)0
Avg Revenue beat(16)-2.39%
PT rev (1m)-0.75%
PT rev (3m)-2%
EPS NQ rev (1m)-14.84%
EPS NQ rev (3m)-15.31%
EPS NY rev (1m)-3.8%
EPS NY rev (3m)-3.86%
Revenue NQ rev (1m)-3.92%
Revenue NQ rev (3m)-4.08%
Revenue NY rev (1m)-1.11%
Revenue NY rev (3m)-1.13%
Valuation
Industry RankSector Rank
PE 12.23
Fwd PE 12.42
P/S 1.22
P/FCF 15.29
P/OCF 12.42
P/B 1.44
P/tB N/A
EV/EBITDA 11.48
EPS(TTM)0.96
EY8.18%
EPS(NY)0.95
Fwd EY8.05%
FCF(TTM)0.77
FCFY6.54%
OCF(TTM)0.95
OCFY8.05%
SpS9.64
BVpS8.17
TBVpS-3.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.28
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -1.48%
ROCE 5.94%
ROIC 4.8%
ROICexc 4.92%
ROICexgc 29.45%
OM 9.18%
PM (TTM) N/A
GM 33.13%
FCFM 7.96%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
ROICexc(3y)6.76%
ROICexc(5y)6.74%
ROICexgc(3y)52.77%
ROICexgc(5y)49.06%
ROCE(3y)8.14%
ROCE(5y)8.11%
ROICexgc growth 3Y9.06%
ROICexgc growth 5Y15.03%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y1.59%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 7.37
Debt/EBITDA 3.6
Cap/Depr 29.62%
Cap/Sales 1.84%
Interest Coverage 3.73
Cash Conversion 63.69%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.96
Altman-Z 1.79
F-Score5
WACC9.46%
ROIC/WACC0.51
Cap/Depr(3y)35.33%
Cap/Depr(5y)30.17%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.71%
Profit Quality(3y)143.28%
Profit Quality(5y)453.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.04%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y-7.13%
EPS Next 2Y-2.78%
EPS Next 3Y2.39%
EPS Next 5Y5.4%
Revenue 1Y (TTM)-3.59%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-5.28%
Revenue Next Year-3.96%
Revenue Next 2Y-1.79%
Revenue Next 3Y0.18%
Revenue Next 5Y1.67%
EBIT growth 1Y-4.14%
EBIT growth 3Y-9.65%
EBIT growth 5Y4.59%
EBIT Next Year2.25%
EBIT Next 3Y4.7%
EBIT Next 5Y3.54%
FCF growth 1Y-24.62%
FCF growth 3Y-6.35%
FCF growth 5Y18.01%
OCF growth 1Y-21.8%
OCF growth 3Y-4.11%
OCF growth 5Y18.89%

AVANTOR INC / AVTR FAQ

What is the ChartMill fundamental rating of AVANTOR INC (AVTR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AVTR.


Can you provide the valuation status for AVANTOR INC?

ChartMill assigns a valuation rating of 7 / 10 to AVANTOR INC (AVTR). This can be considered as Undervalued.


How profitable is AVANTOR INC (AVTR) stock?

AVANTOR INC (AVTR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AVTR stock?

The Price/Earnings (PE) ratio for AVANTOR INC (AVTR) is 12.23 and the Price/Book (PB) ratio is 1.44.


Can you provide the financial health for AVTR stock?

The financial health rating of AVANTOR INC (AVTR) is 2 / 10.